4//SEC Filing
Katz Barrett 4
Accession 0000899243-22-004669
CIK 0001590750other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:13 PM ET
Size
9.8 KB
Accession
0000899243-22-004669
Insider Transaction Report
Form 4
Katz Barrett
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-02+110,000→ 110,000 totalExercise: $18.51Exp: 2032-02-02→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments through February 2, 2026, subject to the Reporting Person's continued service to Issuer through each vesting date.
Issuer
Viridian Therapeutics, Inc.\DE
CIK 0001590750
Entity typeother
Related Parties
1- filerCIK 0001841628
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 6:13 PM ET
- Size
- 9.8 KB